Lee Allman

Olanzapine for young people with anorexia nervosa: a synopsis of the main results from the OPEN open-label feasibility study

Ece Sengun Filiz, Dominic Stringer, Vanessa Kellermann, Rachel Rowan Olive et autres

Background: In clinical practice, olanzapine is commonly used in young people with anorexia nervosa, although the underpinning evidence-base is limited. However, its efficacy, tolerability, acceptability and adherence rate, and the patients', carers' and clinicians' views of olanzapine treatment are unclear. This synopsis …

gb, au (code pays fourni par la source)

Olanzapine for young PEople with aNorexia nervosa (OPEN): results of a feasibility study

Olena Said, Dominic Stringer, Ece Sengun Filiz, Hiba Mutwalli et autres

Despite the availability of evidence-based treatments for anorexia nervosa (AN), remission rates are moderate, and mortality is high. Olanzapine is used as adjunct therapy for AN in case of insufficient response to first-line treatments, even though the evidence is limited. Its effect …

gb, sa, tr, au (code pays fourni par la source)

Olanzapine for young PEople with aNorexia nervosa (OPEN): Results of a feasibility study

Olena Said, Dominic Stringer, Ece Sengun Filiz, Hiba Mutwalli et autres

gb, au (code pays fourni par la source)